Table 2. National Ambulance Surveillance System output variables, including scene patient and clincal details, alcohol, individual illicit drugs and pharmaceutical medication drug classes*.
| Case details | Patient details | Scene details | Physical condition | Illicit drugs | Pharmaceutical medications | Other substances | Intent of AOD poisoning |
|---|---|---|---|---|---|---|---|
| Case number | Gender | Public / private | Patient outcome | Methamphetamine | Opioid analgesics | Alcohol involved | Unintentional |
| Case date | Age | Indoor / outdoor | Pulse rate | Crystal methamphetamine | Other analgesics | Alcohol intoxication | Intentional |
| Case time | Residential postcode | Event postcode | Blood pressure | Cannabis | Benzodiazepines | Inhalant | Undetermined intent |
| Transport to hospital | Homelessness | Event coordinates | Respiratory rate | Synthetic cannabinoids | Anti-depressants | Other substance | |
| Reason for not transporting | Unemployment | Police co-attendance | Skin temperature | Emerging psychoactive substances | Anti-psychotics | ||
| Previous incarceration | Others on scene | Skin moisture | Cocaine | Anti-convulsants | |||
| Culturally and linguistically diverse | Minors on scene | Skin colour | 3,4-methylenedioxy-methamphetamine (MDMA) | Opioid pharmacotherapy treatments | |||
| Refugee background | GCS eye response | Gamma hydroxybutyrate (GHB) | Pharmaceutical stimulants | ||||
| GCS verbal response | Heroin | Peer administered naloxone | |||||
| GCS motor response | Ketamine | Other medication | |||||
| Naloxone administration | Lysergic acid diethylamide (LSD) | ||||||
| Naloxone dose | Mushrooms | ||||||
| Naloxone response | Other illicit drugs |
*Individual pharmaceutical drugs presented in S1 Table